Diabetes

Top Research Topics at Diabetes?

The journal aims to foster the development of research in Internal medicine, Endocrinology, Diabetes mellitus, Insulin and Type 2 diabetes. Insulin resistance, Adipose tissue, Islet, Glucagon and Carbohydrate metabolism are all aspects of Internal medicine discussed in it. The majority of Adipose tissue studies are focused on the issues of Adipocyte.

Pancreatic islets is a focus of the Islet works in the journal. The journal explores research in Endocrinology and the adjacent study of Receptor. The journal focuses on Diabetes mellitus research which is adjacent to topics in Immunology.

The study on Immunology featured in it expounds on the topic of NOD mice in particular. Insulin and Skeletal muscle are closely related fields of research discussed in the journal.

• Internal medicine (67.48%)
• Endocrinology (55.27%)
• Diabetes mellitus (36.04%)

What are the most cited papers published in the journal?

• Role of Insulin Resistance in Human Disease (11040 citations)
• The pathobiology of diabetic complications: a unifying mechanism. (3831 citations)
• Metabolic endotoxemia initiates obesity and insulin resistance (3824 citations)

Research areas of the most cited articles at Diabetes:

The published papers explore disciplines such as Internal medicine, Endocrinology, Diabetes mellitus, Insulin and Insulin resistance. The journal papers focus on Internal medicine research which is adjacent to topics in Type 2 diabetes. The studies on Diabetes mellitus discussed at the most cited publications can also contribute to research in the domains of Immunology and Risk factor.

What topics the last edition of the journal is best known for?

• Internal medicine
• Gene
• Enzyme

The previous edition focused in particular on these issues:

Diabetes focuses on Internal medicine, Diabetes mellitus, Type 2 diabetes, Endocrinology and Type 1 diabetes. The Internal medicine study presented in it encompasses related topics like Insulin, Insulin resistance and Hypoglycemia and also examines its connection to subjects such as In patient. While Diabetes mellitus is the focus of it, it also provided insights into the studies of Pediatrics, Cohort and Family medicine.

It facilitates discussions on Type 2 diabetes that incorporate concepts from other fields like Obesity and Disease. Research on Endocrinology addressed in Diabetes frequently intersections with the field of Inflammation. The majority of Type 1 diabetes studies in the journal are focused on the subject of Insulin pump.

The most cited articles from the last journal are:

• Specific NLRP3 Inhibition Protects Against Diabetes-Associated Atherosclerosis. (10 citations)
• CD31+ Extracellular Vesicles From Patients With Type 2 Diabetes Shuttle a miRNA Signature Associated With Cardiovascular Complications. (10 citations)
• Adaptation of Insulin Clearance to Metabolic Demand Is a Key Determinant of Glucose Tolerance (10 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in Diabetes (based on the number of publications) are:

• Jens J. Holst (157 papers) published 16 papers at the last edition, 9 less than at the previous edition,
• Ralph A. DeFronzo (124 papers) published 7 papers at the last edition, 4 less than at the previous edition,
• Richard N. Bergman (114 papers) published 2 papers at the last edition the same number as at the previous edition,
• Mark A. Atkinson (112 papers) published 12 papers at the last edition, 5 more than at the previous edition,
• Gerald I. Shulman (103 papers) published 5 papers at the last edition, 1 less than at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in Diabetes (based on the number of publications) are:

• Harvard University (536 papers) published 12 papers at the last edition, 6 less than at the previous edition,
• National Institutes of Health (394 papers) published 9 papers at the last edition the same number as at the previous edition,
• Washington University in St. Louis (338 papers) published 5 papers at the last edition, 1 less than at the previous edition,
• University of Washington (294 papers) published 5 papers at the last edition, 3 less than at the previous edition,
• French Institute of Health and Medical Research (264 papers) published 4 papers at the last edition, 2 more than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 78.17% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 21.35% were posted by at least one author from the top 10 institutions publishing in the journal. Another 11.20% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 19.01% of all publications and 48.44% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Career Opportunities in the Field of Diabetes Research

For students and professionals who are fascinated by the interplay of internal medicine, endocrinology, and diabetes, there are numerous career paths and education programs that could pave the way to rewarding work in this field. Registered nurses, for instance, can specialize in endocrinology and diabetes care, providing critical support to patients managing these conditions. Furthering your education in this area could lead to opportunities not just in clinical settings, but also in research, education, public health, and more.

In particular, Licensed Practical Nurse (LPN) programs can offer a fast track to nursing careers with a focus on endocrinology and diabetes. These programs often provide foundational knowledge in nursing theory and practice, along with specific coursework related to diabetes care and management. Graduates may find work in a variety of healthcare settings, including hospitals, outpatient care centers, and nursing care facilities.

If you are based in the Washington area and are considering pursuing an LPN program, it's essential to choose a program that offers a comprehensive curriculum and hands-on training experiences. One resource that can help with this decision is our list of the top {anchor}LPN programs in Washington.

Remember, the journey to a role in diabetes research or care can take many forms. Whether it's through an LPN program or another educational pathway, investing in knowledge and skills in this area can lead to a fulfilling career making a difference in the lives of individuals facing the challenges of diabetes.